HQ Function

The Alachua headquarters served as the core for AGTC's research and development activities, clinical program oversight, manufacturing process development, and corporate operations.

Notable Features:

The facilities included state-of-the-art laboratories designed for gene therapy research, development, and small-scale cGMP manufacturing capabilities, located within Progress Corporate Park, fostering collaboration with other biotech entities.

Work Culture:

AGTC fostered a highly collaborative, science-driven, and patient-focused work culture. The environment encouraged innovation and dedication among its team of scientists, researchers, and professionals aiming to address significant unmet medical needs.

HQ Significance:

This location was pivotal for AGTC's scientific advancements, housing the intellectual capital and infrastructure necessary for developing its pipeline of AAV-based gene therapies from discovery through clinical trials.

Values Reflected in HQ: The headquarters embodied AGTC's commitment to scientific rigor, innovation in genetic medicine, and a focused mission to improve the lives of patients with rare diseases.

Location:

Prior to its acquisition, AGTC's global presence was primarily characterized by its international clinical trial activities for its gene therapy candidates. This involved collaborations with clinical sites and investigators in North America and Europe. The company also engaged with global regulatory bodies like the FDA and EMA. While its physical operational footprint was centered in the US, its research impact and patient recruitment efforts were international.

Street Address:

14193 NW 119th Terrace, Suite 10, Progress Corporate Park

City:

Alachua

State/Province:

Florida

Country:

USA